Development of AVIPure® - AAV9: The first highly reusable AAV affinity resin with NaOH cleaning capabilities
High doses of AAV are becoming increasingly common in gene therapies. In order to meet the growing and ever-changing needs of the biopharmaceutical industry, Avitide has developed the world's first highly reusable affinity chromatography resin with sodium hydroxide (NaOH) cleaning capabilities - AVIPure® - AAV9.
Thomas Scanlon, Ph.D.
Director of Ligand Discovery
Join Tom Scanlon, PhD, Director of Ligand Discovery at Avitide as he discusses Avitide’s affinity resin development platform, AVIPure® - AAV9 Development, and market drivers for AAV resin reuse.
AVIPure® - AAV9 resin is manufactured on site at Avitide headquarters in Lebanon, New Hampshire and is AVAILABLE NOW for commercial manufacturing applications.
https://go.repligen.com/l/463902/2021-11-24/b6wt4n
16 Cavendish Court
Lebanon, NH 03766
603.965.2100
email us
Subscribe to hear the latest news and insights…